While type 2 diabetes is linked with obesity, which increases insulin resistance and accelerates diabetes progression [13, 14], insulin resistance leads to an enhanced sensitivity to the mitogenic effects of insulin, leading to a poorer prognosis in breast cancer patients. This evidence concerns the gene INS and breast carcinoma.